Wednesday, September 17, 2025 9/17/2025

Metabolic dysfunction from ECM remodeling in diseases of human RPE

Award Number: R01EY034364
ORGANIZATION: NATIONAL EYE INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2022
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Metabolic dysfunction from ECM remodeling in diseases of human RPE - PROJECT SUMMARY/ABSTRACT The presence of lipid-rich deposits underneath the retinal pigment epithelium (RPE) is a pathologic feature of early age-related macular degeneration (AMD). Drusen development has been associated with RPE lipid metabolism, redox biology and extracellular matrix (ECM) degradation. Mutations in a gene affecting ECM degradation, tissue inhibitor of metalloproteinase 3 (TIMP3), results in a rare inherited retinal degeneration with similar clinical features to AMD, called Sorsby Fundus Dystrophy (SFD). The mechanism by which abnormal ECM turnover influences lipid metabolism and RPE redox resulting in the formation of sub-RPE deposits remains unknown. The goal of this proposal is to test the hypothesis that ECM degradation overloads the RPE with ECM-derived metabolites, resulting in the reprogramming of RPE towards lipid synthesis and mitochondrial oxidative metabolism. This in turn results in the deposition of excess lipids and reduced antioxidative capacity of the RPE. The proposed specific aims are: Aim 1. Determine the influence of ECM degradation on lipid metabolism. Our preliminary results show that increased ECM degradation in SFD RPE activates lipid synthesis and oxidation of branch-chain amino acids (BCAAs). BCAAs are ketogenic and abundant in the ECM. The goal of Aim 1 is to test the hypothesis that ECM degradation of protein-rich components reprograms RPE metabolism towards enhanced BCAA oxidation for lipid synthesis and lipid deposition. We will use quantitative proteomics, quantitative metabolomics, metabolic flux analysis, perifusion assays, CRISPR/Cas9 gene-editing, and single cell nuclear RNA-Seq of patient-derived iPSC RPE to comprehensively investigate the metabolic pathways in ECM remodeling and lipid deposition. Aim 2. Determine the influence of ECM degradation on redox metabolism. Our preliminary data show that both NADPH and glutathione are depleted in SFD RPE, and ECM-derived metabolites interfere with NADPH and glutathione metabolism. The goal of Aim 2 is to test the hypothesis that increased ECM turnover results in impaired NADPH and glutathione metabolism. We will quantify the metabolic flux of ECM degradation, determine the roles of ECM-related metabolites in NADPH production and glutathione synthesis, and restore cellular redox with different approaches to enhance antioxidative capacity. The proposed research will define the biochemical impacts of ECM turnover on RPE metabolism, including changes in lipid metabolism and oxidative stress, and identify the relationship between nutrient metabolism, protein synthesis and degradation, and redox biology in normal and disease-relevant RPE.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $543,177 )
2025	2025	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Vision Research	000	4	8/4/2025	NON-COMPETING CONTINUATION	$543,177
														Subtotal = $543,177

Issue Date FY: 2024 ( Subtotal = $564,318 )
2024	2024	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Vision Research	000	3	7/11/2024	NON-COMPETING CONTINUATION	$564,318
														Subtotal = $564,318

Issue Date FY: 2023 ( Subtotal = $567,717 )
2023	2023	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Vision Research	000	2	6/8/2023	NON-COMPETING CONTINUATION	$567,717
														Subtotal = $567,717

Issue Date FY: 2022 ( Subtotal = $599,199 )
2022	2022	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Vision Research	000	1	8/9/2022	NEW	$599,199
														Subtotal = $599,199

Grand Total All Awards = $2,274,411

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Metabolic dysfunction from ECM remodeling in diseases of human RPE

Award Number: R01EY034364

ORGANIZATION: NATIONAL EYE INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2022

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer